Grantham, Mayo, Van Otterloo & Co (GMO)
CBM

Grantham, Mayo, Van Otterloo & Co (GMO)’s Cambrex Corporation CBM Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CBM Stock Details CBM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,400
Closed -$263K – 660
2017
Q2 		$263K Hold
4,400
– – ﹤0.01% 496
2017
Q1 		$242K Buy
+4,400
New +$235K ﹤0.01% 476

Other funds holding CBM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CBM Position: Q3 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Cambrex Corporation (CBM) in Q3 2017, closing a stake of 4,400 shares — an estimated $263K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CBM in Q1 2017 and held it in 2 quarters. The position peaked at $263K in Q2 2017. 257 funds tracked by Wall St. Rank hold CBM as of Q3 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Cambrex Corporation position as of Q3 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,400 Cambrex Corporation shares in Q3 2017, an estimated $263K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cambrex Corporation in Q1 2017 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Cambrex Corporation position peaked at $263K in Q2 2017.
  • 257 funds tracked by Wall St. Rank held Cambrex Corporation as of Q3 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2017, filed 14 Nov 2017.